D.E. Shaw & Co’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,900
| Closed | -$686K | – | 4927 |
|
|
2025
Q2 | $686K | Sell |
3,900
-56,700
| -94% | -$8.53M | ﹤0.01% | 3482 |
|
|
2025
Q1 | $8.15M | Buy |
60,600
+30,000
| +98% | +$3.95M | 0.01% | 1542 |
|
|
2024
Q4 | $3.86M | Sell |
30,600
-5,400
| -15% | -$803K | ﹤0.01% | 2191 |
|
|
2024
Q3 | $5.98M | Hold |
36,000
| – | – | 0.01% | 1800 |
|
|
2024
Q2 | $4.79M | Buy |
+36,000
| New | +$4.33M | ﹤0.01% | 1886 |
|
|
2024
Q1 | – | Sell |
-16,900
| Closed | -$1.28M | – | 4736 |
|
|
2023
Q4 | $1.28M | Hold |
16,900
| – | – | ﹤0.01% | 2968 |
|
|
2023
Q3 | $1.11M | Hold |
16,900
| – | – | ﹤0.01% | 2998 |
|
|
2023
Q2 | $1.38M | Buy |
+16,900
| New | +$1.2M | ﹤0.01% | 2896 |
|
|
2022
Q2 | – | Sell |
-75,000
| Closed | -$6.45M | – | 5773 |
|
|
2022
Q1 | $6.45M | Buy |
75,000
+37,100
| +98% | +$3.05M | 0.01% | 2033 |
|
|
2021
Q4 | $3.1M | Buy |
+37,900
| New | +$2.77M | ﹤0.01% | 2920 |
|
|
2021
Q3 | – | Sell |
-25,200
| Closed | -$1.69M | – | 5234 |
|
|
2021
Q2 | $1.69M | Buy |
25,200
+6,600
| +35% | +$409K | ﹤0.01% | 3105 |
|
|
2021
Q1 | $967K | Buy |
+18,600
| New | +$940K | ﹤0.01% | 3143 |
|
|
2020
Q1 | – | Sell |
-30,000
| Closed | -$1.14M | – | 4256 |
|
|
2019
Q4 | $1.14M | Buy |
+30,000
| New | +$899K | ﹤0.01% | 2888 |
|
|
2019
Q1 | – | Sell |
-14,200
| Closed | -$243K | – | 3926 |
|
|
2018
Q4 | $243K | Sell |
14,200
-18,600
| -57% | -$450K | ﹤0.01% | 3456 |
|
|
2018
Q3 | $933K | Buy |
32,800
+16,700
| +104% | +$551K | ﹤0.01% | 2735 |
|
|
2018
Q2 | $540K | Sell |
16,100
-23,900
| -60% | -$743K | ﹤0.01% | 3073 |
|
|
2018
Q1 | $970K | Buy |
+40,000
| New | +$796K | ﹤0.01% | 2510 |
|
|
2016
Q1 | – | Sell |
-125,600
| Closed | -$3.81M | – | 3767 |
|
|
2015
Q4 | $3.81M | Buy |
125,600
+95,600
| +319% | +$3.14M | 0.01% | 1625 |
|
|
2015
Q3 | $1.11M | Hold |
30,000
| – | – | ﹤0.01% | 2532 |
|
|
2015
Q2 | $1.74M | Hold |
30,000
| – | – | ﹤0.01% | 2298 |
|
|
2015
Q1 | $1.49M | Hold |
30,000
| – | – | ﹤0.01% | 2246 |
|
|
2014
Q4 | $1.52M | Hold |
30,000
| – | – | ﹤0.01% | 2495 |
|
|
2014
Q3 | $1.78M | Buy |
+30,000
| New | +$1.67M | ﹤0.01% | 2336 |
|
|
2014
Q1 | – | Sell |
-111,500
| Closed | -$4.7M | – | 4613 |
|
|
2013
Q4 | $4.7M | Hold |
111,500
| – | – | 0.01% | 1727 |
|
|
2013
Q3 | $4.59M | Sell |
111,500
-55,000
| -33% | -$2.3M | 0.01% | 1677 |
|
|
2013
Q2 | $7.68M | Buy |
+166,500
| New | +$7.45M | 0.01% | 1047 |
|
Other funds holding THC
VPM
VCM
LPC
D.E. Shaw & Co's THC Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Tenet Healthcare (THC) stake by 78% in Q1 2026, selling an estimated $196M and leaving 260,069 shares worth $49.1M. The position accounts for 0.03% of the portfolio, ranked #669.
D.E. Shaw & Co first reported a position in THC in Q3 2013 and has held it in 46 quarters since. The position peaked at $236M in Q4 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- D.E. Shaw & Co held 260,069 shares of Tenet Healthcare worth $49.1M as of Q1 2026.
- D.E. Shaw & Co sold 929,443 Tenet Healthcare shares in Q1 2026, an estimated $196M.
- Tenet Healthcare made up 0.03% of D.E. Shaw & Co's portfolio in Q1 2026, its #669 holding.
- D.E. Shaw & Co first reported a position in Tenet Healthcare in Q3 2013 and has held it in 46 quarters since.
- D.E. Shaw & Co's Tenet Healthcare position peaked at $236M in Q4 2025.
- 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.